-
Mutation of the MXI1 gene in prostate cancer.
Nat Genet. 1995 Mar;9(3):249-55
PMID: 7773287
-
The MYC protein activates transcription of the alpha-prothymosin gene.
EMBO J. 1991 Jan;10(1):133-41
PMID: 1989881
-
Differential effects by Mad and Max on transformation by cellular and viral oncoproteins.
Oncogene. 1995 Aug 3;11(3):587-96
PMID: 7630643
-
Cloning and characterization of murine p16INK4a and p15INK4b genes.
Oncogene. 1995 Aug 17;11(4):635-45
PMID: 7651726
-
Repression of Myc-Ras cotransformation by Mad is mediated by multiple protein-protein interactions.
Cell Growth Differ. 1995 Jun;6(6):623-9
PMID: 7669717
-
BCR first exon sequences specifically activate the BCR/ABL tyrosine kinase oncogene of Philadelphia chromosome-positive human leukemias.
Mol Cell Biol. 1991 Apr;11(4):1785-92
PMID: 2005881
-
Myc rescue of a mutant CSF-1 receptor impaired in mitogenic signalling.
Nature. 1991 Sep 26;353(6342):361-3
PMID: 1833648
-
IL-2 and EGF receptors stimulate the hematopoietic cell cycle via different signaling pathways: demonstration of a novel role for c-myc.
Cell. 1992 Jul 10;70(1):57-67
PMID: 1535827
-
Myc and Max function as a nucleoprotein complex.
Curr Opin Genet Dev. 1992 Apr;2(2):227-35
PMID: 1638116
-
Mitosis-specific phosphorylation of the nuclear oncoproteins Myc and Myb.
J Cell Biol. 1992 Aug;118(4):775-84
PMID: 1500422
-
p53 function and dysfunction.
Cell. 1992 Aug 21;70(4):523-6
PMID: 1505019
-
The functions of Myc proteins.
Biochim Biophys Acta. 1992 Dec 16;1114(2-3):129-46
PMID: 1457461
-
Mad: a heterodimeric partner for Max that antagonizes Myc transcriptional activity.
Cell. 1993 Jan 29;72(2):211-22
PMID: 8425218
-
Mxi1, a protein that specifically interacts with Max to bind Myc-Max recognition sites.
Cell. 1993 Jan 29;72(2):223-32
PMID: 8425219
-
Cyclin D1 is a nuclear protein required for cell cycle progression in G1.
Genes Dev. 1993 May;7(5):812-21
PMID: 8491378
-
Cell cycle regulation of the c-Myc transcriptional activation domain.
Mol Cell Biol. 1993 Jul;13(7):4125-36
PMID: 8321217
-
Overexpression of mouse D-type cyclins accelerates G1 phase in rodent fibroblasts.
Genes Dev. 1993 Aug;7(8):1559-71
PMID: 8339933
-
Production of high-titer helper-free retroviruses by transient transfection.
Proc Natl Acad Sci U S A. 1993 Sep 15;90(18):8392-6
PMID: 7690960
-
A switch from Myc:Max to Mad:Max heterocomplexes accompanies monocyte/macrophage differentiation.
Genes Dev. 1993 Nov;7(11):2110-9
PMID: 8224841
-
WAF1, a potential mediator of p53 tumor suppression.
Cell. 1993 Nov 19;75(4):817-25
PMID: 8242752
-
Acceleration of the G1/S phase transition by expression of cyclins D1 and E with an inducible system.
Mol Cell Biol. 1994 Mar;14(3):1669-79
PMID: 8114703
-
Expression of mad, mxi1, max and c-myc during induced differentiation of hematopoietic cells: opposite regulation of mad and c-myc.
Oncogene. 1994 Apr;9(4):1247-52
PMID: 8134128
-
Myc-Max-Mad: a transcription factor network controlling cell cycle progression, differentiation and death.
Curr Opin Genet Dev. 1994 Feb;4(1):102-8
PMID: 8193530
-
Suppression of Myc, but not E1a, transformation activity by Max-associated proteins, Mad and Mxi1.
Proc Natl Acad Sci U S A. 1994 Jun 7;91(12):5503-7
PMID: 8202517
-
Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD.
Science. 1995 Feb 17;267(5200):1018-21
PMID: 7863327
-
p53-independent expression of p21Cip1 in muscle and other terminally differentiating cells.
Science. 1995 Feb 17;267(5200):1024-7
PMID: 7863329
-
Mad-Max transcriptional repression is mediated by ternary complex formation with mammalian homologs of yeast repressor Sin3.
Cell. 1995 Mar 10;80(5):767-76
PMID: 7889570
-
An amino-terminal domain of Mxi1 mediates anti-Myc oncogenic activity and interacts with a homolog of the yeast transcriptional repressor SIN3.
Cell. 1995 Mar 10;80(5):777-86
PMID: 7889571
-
Expression of the mad gene during cell differentiation in vivo and its inhibition of cell growth in vitro.
J Cell Biol. 1995 Mar;128(6):1197-208
PMID: 7896882
-
Differential regulation of Max and role of c-Myc during erythroid and myelomonocytic differentiation of K562 cells.
Oncogene. 1995 Apr 20;10(8):1659-65
PMID: 7731722
-
The retinoblastoma protein and cell cycle control.
Cell. 1995 May 5;81(3):323-30
PMID: 7736585
-
Novel INK4 proteins, p19 and p18, are specific inhibitors of the cyclin D-dependent kinases CDK4 and CDK6.
Mol Cell Biol. 1995 May;15(5):2672-81
PMID: 7739547
-
Effects of the MYC oncogene antagonist, MAD, on proliferation, cell cycling and the malignant phenotype of human brain tumour cells.
Nat Med. 1995 Jul;1(7):638-43
PMID: 7585143
-
Mad3 and Mad4: novel Max-interacting transcriptional repressors that suppress c-myc dependent transformation and are expressed during neural and epidermal differentiation.
EMBO J. 1995 Nov 15;14(22):5646-59
PMID: 8521822
-
Regulation of Myc and Mad during epidermal differentiation and HPV-associated tumorigenesis.
Oncogene. 1995 Dec 21;11(12):2487-501
PMID: 8545105
-
Quantitative variation of the common acute lymphoblastic leukemia antigen (gp100) on leukemic marrow blasts.
J Clin Invest. 1984 Jun;73(6):1617-28
PMID: 6233301
-
Levels of c-myc oncogene mRNA are invariant throughout the cell cycle.
Nature. 1985 Mar 28-Apr 3;314(6009):363-6
PMID: 3982504
-
c-myc oncogene protein synthesis is independent of the cell cycle in human and avian cells.
Nature. 1985 Mar 28-Apr 3;314(6009):366-9
PMID: 3885045
-
Transforming potential of the c-fms proto-oncogene (CSF-1 receptor).
Nature. 1987 Feb 5-11;325(6104):549-52
PMID: 3027579
-
A c-myc antisense oligodeoxynucleotide inhibits entry into S phase but not progress from G0 to G1.
Nature. 1987 Jul 30-Aug 5;328(6129):445-9
PMID: 3302722
-
High-efficiency transformation of mammalian cells by plasmid DNA.
Mol Cell Biol. 1987 Aug;7(8):2745-52
PMID: 3670292
-
Enforced expression of the c-myc oncogene inhibits cell differentiation by precluding entry into a distinct predifferentiation state in G0/G1.
Mol Cell Biol. 1988 Apr;8(4):1614-24
PMID: 2454393
-
Rescue of defective mitogenic signaling by D-type cyclins.
Proc Natl Acad Sci U S A. 1995 Jul 18;92(15):6837-41
PMID: 7624328